FOXP3 and myalgic encephalomeyelitis/chronic fatigue syndrome: However, a follow-up study showed an elevated expression of VPACR2—the VIP receptor—in immune cells and an increased frequency of the regulatory Foxp3+CD4+ T cells in ME/CFS patients in comparison with HCs [106].